Conference
THRIVE I: Efficacy and tolerability of the novel, oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis.
Authors
Schulman S; Wahlander K; Gustafsson D; Welin L; Frison L; Eriksson H
Volume
98
Pagination
pp. 447A-448A
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 16, 2001
Conference proceedings
BLOOD
Issue
11
ISSN
0006-4971